Tonghua Dongbao Pharmaceutical Co Ltd
SSE:600867
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
Tonghua Dongbao Pharmaceutical Co Ltd
SSE:600867
|
CN |
|
Nippon Signal Co Ltd
TSE:6741
|
JP |
|
I
|
IPS Inc
TSE:4390
|
JP |
|
P
|
PetroVietnam Power Engineering Consulting JSC
VN:PPE
|
VN |
|
Recon Technology Ltd
NASDAQ:RCON
|
CN |
|
A
|
Astron Paper & Board Mill Ltd
NSE:ASTRON
|
IN |
|
Reading International Inc
NASDAQ:RDI
|
US |
|
M
|
Manjeera Constructions Ltd
BSE:533078
|
IN |
|
Cabot Corp
NYSE:CBT
|
US |
|
C
|
Cronos Group Inc
NASDAQ:CRON
|
CA |
|
Thai Beverage PCL
OTC:TBVPF
|
TH |
|
G
|
General Commercial and Industrial SA
ATHEX:GEBKA
|
GR |
|
Pet Valu Holdings Ltd
TSX:PET
|
CA |
|
GMO Pepabo Inc
TSE:3633
|
JP |
|
Industria de Diseno Textil SA
OTC:IDEXY
|
ES |
|
F
|
Ffbw Inc
OTC:FFBW
|
US |
|
Minerals Technologies Inc
NYSE:MTX
|
US |
|
Baioo Family Interactive Ltd
HKEX:2100
|
CN |
|
Eastman Chemical Co
NYSE:EMN
|
US |
|
Guardant Health Inc
NASDAQ:GH
|
US |
Wall Street
Price Targets
Price Targets Summary
Tonghua Dongbao Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for Tonghua Dongbao Pharmaceutical Co Ltd is 11.19 CNY with a low forecast of 8.08 CNY and a high forecast of 14.7 CNY.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Tonghua Dongbao Pharmaceutical Co Ltd's stock price target?
Price Target
11.19
CNY
According to Wall Street analysts, the average 1-year price target for Tonghua Dongbao Pharmaceutical Co Ltd is 11.19 CNY with a low forecast of 8.08 CNY and a high forecast of 14.7 CNY.
What is Tonghua Dongbao Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
22%
For the last 13 years the compound annual growth rate for Tonghua Dongbao Pharmaceutical Co Ltd's revenue is 8%. The projected CAGR for the next 3 years is 22%.
What is Tonghua Dongbao Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
104%
For the last 13 years the compound annual growth rate for Tonghua Dongbao Pharmaceutical Co Ltd's operating income is 11%. The projected CAGR for the next 3 years is 104%.
